Robert F. Apple
Direttore/Membro del Consiglio presso KAZIA THERAPEUTICS LIMITED
Posizioni attive di Robert F. Apple
Società | Posizione | Inizio | Fine |
---|---|---|---|
KAZIA THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 18/01/2024 | - |
Storia della carriera di Robert F. Apple
Precedenti posizioni note di Robert F. Apple
Società | Posizione | Inizio | Fine |
---|---|---|---|
ANTARES PHARMA, INC. | Comptroller/Controller/Auditor | 08/06/2010 | 05/07/2012 |
Direttore/Membro del Consiglio | 04/03/2016 | 24/05/2022 | |
Amministratore Delegato | 24/01/2016 | 24/05/2022 | |
Direttore operativo | 15/09/2014 | 24/01/2016 | |
Direttore Finanziario/CFO | 01/02/2006 | 18/11/2014 | |
Presidente | 24/01/2016 | 24/05/2022 | |
Segretario Aziendale | 01/02/2006 | 15/09/2014 | |
PAXMEDICA, INC. | Direttore/Membro del Consiglio | 01/06/2020 | 01/04/2022 |
Independent Dir/Board Member | 01/06/2020 | 01/04/2022 | |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Direttore operativo | 01/01/2003 | 01/01/2005 |
Direttore Finanziario/CFO | 01/01/1997 | 01/01/2002 | |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Comptroller/Controller/Auditor | 01/01/1995 | 01/10/1997 |
Liberty Technologies, Inc. /Pennsylvania/ | Comptroller/Controller/Auditor | 01/05/1994 | 01/07/1995 |
Kerathin LLC
Kerathin LLC Medical SpecialtiesHealth Technology Kerathin LLC manufactured medical devices for the treatment of diseased and dystrophic nails. It offered podiaPRO-H1, a device that provides improvement in nail debridement. The company was founded by Tom Fitzsimons and Beth Fitzsimons in May 2010 and was headquartered in Chester, PA. | Direttore/Membro del Consiglio | - | - |
Formazione di Robert F. Apple
Temple University (Pennsylvania) | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Australia | 2 |
Posizioni
Director/Board Member | 4 |
Comptroller/Controller/Auditor | 3 |
Chief Operating Officer | 2 |
Settori
Health Technology | 7 |
Electronic Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
KAZIA THERAPEUTICS LIMITED | Health Technology |
PAXMEDICA, INC. | Health Technology |
Aziende private | 5 |
---|---|
Liberty Technologies, Inc. /Pennsylvania/ | Electronic Technology |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Kerathin LLC
Kerathin LLC Medical SpecialtiesHealth Technology Kerathin LLC manufactured medical devices for the treatment of diseased and dystrophic nails. It offered podiaPRO-H1, a device that provides improvement in nail debridement. The company was founded by Tom Fitzsimons and Beth Fitzsimons in May 2010 and was headquartered in Chester, PA. | Health Technology |
- Borsa valori
- Insiders
- Robert F. Apple
- Esperienza